A.R.T. Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

A.R.T. Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,271	Closed	-$131K	–	1835
2019 Q3	$131K	Buy	+20,271	New	+$140K	0.01%	1242
2018 Q2	–	Sell	-52,038	Closed	-$553K	–	1857
2018 Q1	$553K	Buy	52,038 +31,134	+149%	+$500K	0.02%	914
2017 Q4	$881K	Buy	20,904 +11,643	+126%	+$522K	0.04%	673
2017 Q3	$509K	Buy	9,261 +3,225	+53%	+$544K	0.03%	821
2017 Q2	$1.12M	Buy	+6,036	New	+$1.06M	0.06%	471
2016 Q3	–	Sell	-5,763	Closed	-$591K	–	1272
2016 Q2	$591K	Buy	+5,763	New	+$576K	0.03%	747

Other funds holding SIOX

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

A.R.T. Advisors's SIOX Position: Q4 2019 in Review

A.R.T. Advisors sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2019, closing a stake of 20,271 shares — an estimated $131K sold.

A.R.T. Advisors first reported a position in SIOX in Q2 2016 and held it in 6 quarters. The position peaked at $1.12M in Q2 2017. 48 funds tracked by Wall St. Rank hold SIOX as of Q4 2019.

A.R.T. Advisors reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 20,271 Sio Gene Therapies Inc. Common Stock shares in Q4 2019, an estimated $131K.
A.R.T. Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2016 and held it in 6 quarters.
A.R.T. Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $1.12M in Q2 2017.
48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.